Research

Hormonal

Brainstem cholecystokinin-expressing (CCKAP/NTS) neurons are required for the appetite-suppressing and body-weight-lowering effects of GLP-1 receptor agonists.

GLP-1 medications like semaglutide or liraglutide work by activating specific neurons in the brainstem (CCK neurons). If these neurons are blocked or non-functional, the medication will not suppress appetite or reduce body weight. This highlights that the drug's efficacy depends on this specific neural pathway.

GoodSupportsHIGH confidence
We found that cholecystokinin-expressing neurons in the caudal brainstem are required for the anorectic and body weight-lowering effects of GLP-1RAs
Alessia Costa et al. · Molecular Metabolism · 2021

Why this rating

High-quality mechanistic evidence using genetic loss-of-function (TeLC) in mice and non-human primates.

Source

Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation

Alessia Costa et al. · Molecular Metabolism · 2021

DOI 10.1016/j.molmet.2021.101407

mechanism_onlyCited 72×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →